Summary by Moomoo AI
Biora Therapeutics, a clinical-stage biotechnology company, has announced the offering of 5,454,548 shares of its common stock at a price of $1.10 per share to certain institutional investors. The offering is made pursuant to a prospectus supplement and the accompanying prospectus dated August 6, 2021. Concurrently, Biora Therapeutics is issuing warrants to purchase an additional 5,454,548 shares of common stock, representing 100% of the shares purchased in the offering. These warrants will be exercisable upon stockholder approval at the same price of $1.10 per share and will have a term of five years from the date of approval. The warrants and the shares issuable upon exercise are not being registered under the Securities Act of 1933, as amended, and are being offered pursuant to an exemption provided...Show More